Schenkein David P (CIK 1578200) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy DNLI (6,408 shares), Buy REGN (155 shares), Buy DNLI (6,037 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,408 | $0 |
| 2026-01-06 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Buy | 155 | $0 |
| 2025-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,037 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05